GYRE Gyre Therapeutics Inc notches 102 percent year over year revenue growth shares climb despite modest EPS miss Invesco CurrencyShares Japanese Yen Trust FXY Market Analysis Report DEI Douglas Emmett Inc posts narrower Q4 2025 loss than estimates shares climb 245 percent GE GE Aerospace posts Q4 2025 earnings beat and 185 percent revenue growth shares edge lower today